Wound care biologics market to grow to $6.24B by 2035, driven by chronic wounds and advanced therapies.

The wound care biologics market is projected to grow from $2.80 billion in 2025 to $6.24 billion by 2035, at a CAGR of 8.48%. Growth is driven by rising chronic wounds such as diabetic foot ulcers, an aging population, and increased use of advanced biologics like skin substitutes. North America leads the market, while Asia-Pacific is the fastest-growing region. Innovations in cell-based therapies and expanding healthcare infrastructure will support continued market expansion.